Robert Lisicki Arena Pharmaceuticals Inc (ARNA) insider trading activity

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held N/A

Robert Lisicki Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 11 2022	SELL Other acquisition or disposition	-	37,563 Reduced 100.0%	0 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	21,462 Added 36.36%	37,563 Common Stock
Aug 03 2021	SELL Open market or private sale	$1,050,350 $60.02 p/Share	17,500 Reduced 52.08%	16,101 Common Stock
Aug 03 2021	BUY Exercise of conversion of derivative security	$716,625 $40.95 p/Share	17,500 Added 34.25%	33,601 Common Stock
Mar 01 2021	BUY Grant, award, or other acquisition	-	6,660 Added 29.26%	16,101 Common Stock
Feb 02 2021	SELL Open market or private sale	$1,374,100 $78.52 p/Share	17,500 Reduced 64.96%	9,441 Common Stock
Feb 02 2021	BUY Exercise of conversion of derivative security	$716,625 $40.95 p/Share	17,500 Added 39.38%	26,941 Common Stock
Jan 07 2021	SELL Payment of exercise price or tax liability	$245,107 $77.59 p/Share	3,159 Reduced 25.07%	9,441 Common Stock
Jan 07 2021	BUY Exercise of conversion of derivative security	-	12,600 Added 50.0%	12,600 Common Stock
Dec 01 2020	SELL Open market or private sale	$255,087 $65.88 p/Share	3,872 Reduced 100.0%	0 Common Stock
Nov 25 2020	SELL Payment of exercise price or tax liability	$159,034 $65.5 p/Share	2,428 Reduced 38.54%	3,872 Common Stock
Nov 25 2020	BUY Exercise of conversion of derivative security	-	6,300 Added 50.0%	6,300 Common Stock

JATT-WT

JATT Acquisition Corp

Chief Executive Officer

CVKD

Cadrenal Therapeutics, Inc.

Director

EVP, Chief Commercial Officer

San Diego, CA

Receive a notification when an Institution or Guru buys or sells ARNA shares.

Notify only if

Value

Get notified when an Arena Pharmaceuticals Inc insider buys or sells ARNA shares.

Notify only if

Operation

Value

Type

Receive news related to ARENA PHARMACEUTICALS INC